NASDAQ:HSDT Helius Medical Technologies (HSDT) Stock Price, News & Analysis → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free HSDT Stock Alerts $4.50 +0.06 (+1.35%) (As of 05:27 PM ET) Add Compare Share Share Today's Range$4.42▼$4.6950-Day Range$4.41▼$6.4852-Week Range$4.29▼$14.44Volume5,124 shsAverage Volume316,342 shsMarket Capitalization$4.01 millionP/E RatioN/ADividend YieldN/APrice Target$54.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Get Helius Medical Technologies alerts: Email Address Helius Medical Technologies MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside1,111.1% Upside$54.50 Price TargetShort InterestHealthy8.52% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($7.42) to ($2.20) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.20 out of 5 stars 3.5 Analyst's Opinion Consensus RatingHelius Medical Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageHelius Medical Technologies has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted8.52% of the float of Helius Medical Technologies has been sold short.Short Interest Ratio / Days to CoverHelius Medical Technologies has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Helius Medical Technologies has recently decreased by 0.14%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldHelius Medical Technologies does not currently pay a dividend.Dividend GrowthHelius Medical Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HSDT. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 3 news articles for Helius Medical Technologies this week, compared to 1 article on an average week.MarketBeat Follows4 people have added Helius Medical Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Helius Medical Technologies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 7.30% of the stock of Helius Medical Technologies is held by insiders.Percentage Held by InstitutionsOnly 18.63% of the stock of Helius Medical Technologies is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Helius Medical Technologies are expected to grow in the coming year, from ($7.42) to ($2.20) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Helius Medical Technologies is -0.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Helius Medical Technologies is -0.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHelius Medical Technologies has a P/B Ratio of 1.36. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 About Helius Medical Technologies Stock (NASDAQ:HSDT)Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.Read More HSDT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HSDT Stock News HeadlinesApril 24, 2024 | globenewswire.comHelius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd CenterApril 21, 2024 | finance.yahoo.comHelius Medical Technologies, Inc. (HSDT)April 26, 2024 | True Market Insiders (Ad)Exposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…April 20, 2024 | americanbankingnews.comFinancial Survey: Helius Medical Technologies (NASDAQ:HSDT) & NeurAxis (NASDAQ:NRXS)April 17, 2024 | wsj.comHelius Medical Technologies Inc.April 15, 2024 | msn.comHelius Medical files to sell Class A common stock, warrantsApril 6, 2024 | msn.comHelius Medical Technologies Partners with Lovell to Bring Innovative MS Treatment to VeteransApril 3, 2024 | msn.comWhy Is Nano-Cap Helius Medical Stock Trading Higher On Wednesday?April 26, 2024 | True Market Insiders (Ad)Exposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…April 3, 2024 | seekingalpha.comHelius Medical Technologies signs partnership with Lovell Government ServicesApril 3, 2024 | globenewswire.comHelius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™April 1, 2024 | finance.yahoo.comHelius Medical Technologies, Inc. (NASDAQ:HSDT) Q4 2023 Earnings Call TranscriptMarch 30, 2024 | seekingalpha.comHelius Medical Technologies, Inc. (HSDT) Q4 2023 Earnings Call TranscriptMarch 29, 2024 | finance.yahoo.comQ4 2023 Helius Medical Technologies Inc Earnings CallMarch 28, 2024 | msn.comHelius Medical Technologies GAAP EPS of -$1.47 beats by $2.30, revenue of $0.13M misses by $0.12MMarch 28, 2024 | globenewswire.comHelius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 19, 2024 | msn.comHelius Medical Technologies to Unveil Key Financial Results and U.S. Commercialization Plans for PoNSMarch 15, 2024 | globenewswire.comHelius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024March 12, 2024 | globenewswire.comHelius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in StrokeMarch 11, 2024 | msn.comHelius Medical Technologies to Showcase Neurotech Innovations at the 36th Annual ROTH ConferenceMarch 7, 2024 | globenewswire.comHelius Medical Technologies, Inc. to Present at the 36th Annual ROTH ConferenceMarch 4, 2024 | marketwatch.comHelius Medical Shares Climb As PoNS Treatment Nears Reimbursement MilestoneMarch 4, 2024 | msn.comHelius Medical stock rallies 19% on CMS code assignmentsMarch 4, 2024 | msn.comWhy Is Neurotech-Focused Helius Medical Trading Higher On Monday?March 4, 2024 | globenewswire.comHelius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and ControllerFebruary 22, 2024 | investing.comHelius Medical Technologies Inc Class A (HSDT)February 7, 2024 | msn.comHelius Medical Technologies Amplifies Presence at 2024 APTA Combined Sections MeetingSee More Headlines Receive HSDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Helius Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/28/2024Today4/26/2024Next Earnings (Estimated)5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:HSDT CUSIPN/A CIK1610853 Webheliusmedical.com Phone(877) 564-0008FaxN/AEmployees26Year Founded2014Price Target and Rating Average Stock Price Target$54.50 High Stock Price Target$85.00 Low Stock Price Target$24.00 Potential Upside/Downside+1,111.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($14.46) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,850,000.00 Net Margins-1,374.22% Pretax Margin-1,374.22% Return on Equity-221.11% Return on Assets-86.23% Debt Debt-to-Equity RatioN/A Current Ratio3.96 Quick Ratio3.72 Sales & Book Value Annual Sales$640,000.00 Price / Sales6.26 Cash FlowN/A Price / Cash FlowN/A Book Value$3.32 per share Price / Book1.36Miscellaneous Outstanding Shares890,000Free Float822,000Market Cap$4.01 million OptionableNot Optionable Beta1.44 Social Links Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Dane Carl Andreeff (Age 58)President, CEO & Director Comp: $469.17kDr. Antonella Favit-Van Pelt M.D. (Age 57)Ph.D., Chief Medical Officer Comp: $432.67kMr. Lawrence PiccianoSenior Vice President of Engineering, Quality & Regulatory AffairsKey CompetitorsENDRA Life SciencesNASDAQ:NDRANuwellisNASDAQ:NUWETivic Health SystemsNASDAQ:TIVCStar EquityNASDAQ:STRRBioSig TechnologiesNASDAQ:BSGMView All CompetitorsInsidersDane AndreeffBought 5,000 shares on 12/14/2023Total: $40,500.00 ($8.10/share)Dane AndreeffBought 2,000 shares on 11/30/2023Total: $12,740.00 ($6.37/share)Dane AndreeffBought 5,000 shares on 8/30/2023Total: $38,200.00 ($7.64/share)Dane AndreeffBought 5,078 shares on 8/28/2023Total: $32,346.86 ($6.37/share)View All Insider Transactions HSDT Stock Analysis - Frequently Asked Questions Should I buy or sell Helius Medical Technologies stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Helius Medical Technologies in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" HSDT shares. View HSDT analyst ratings or view top-rated stocks. What is Helius Medical Technologies' stock price target for 2024? 1 equities research analysts have issued 1 year price objectives for Helius Medical Technologies' shares. Their HSDT share price targets range from $24.00 to $85.00. On average, they predict the company's share price to reach $54.50 in the next twelve months. This suggests a possible upside of 1,111.1% from the stock's current price. View analysts price targets for HSDT or view top-rated stocks among Wall Street analysts. How have HSDT shares performed in 2024? Helius Medical Technologies' stock was trading at $8.04 at the beginning of 2024. Since then, HSDT stock has decreased by 44.0% and is now trading at $4.50. View the best growth stocks for 2024 here. Are investors shorting Helius Medical Technologies? Helius Medical Technologies saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 72,200 shares, a decrease of 35.4% from the March 15th total of 111,800 shares. Based on an average daily trading volume, of 391,300 shares, the days-to-cover ratio is currently 0.2 days. Approximately 8.5% of the company's stock are short sold. View Helius Medical Technologies' Short Interest. When is Helius Medical Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our HSDT earnings forecast. How were Helius Medical Technologies' earnings last quarter? Helius Medical Technologies, Inc. (NASDAQ:HSDT) issued its earnings results on Thursday, March, 28th. The company reported ($1.47) EPS for the quarter, topping the consensus estimate of ($4.05) by $2.58. The company earned $0.13 million during the quarter, compared to analysts' expectations of $0.18 million. Helius Medical Technologies had a negative trailing twelve-month return on equity of 221.11% and a negative net margin of 1,374.22%. When did Helius Medical Technologies' stock split? Helius Medical Technologies shares reverse split on Thursday, August 17th 2023. The 1-50 reverse split was announced on Thursday, August 17th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, August 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. How do I buy shares of Helius Medical Technologies? Shares of HSDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HSDT) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helius Medical Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
